Sep 26, 2023
Currently no approved therapies exist to target obesity-related heart failure with preserved ejection fraction, a condition increasing in prevalence and associated with high symptom burden. In this interview, Mikhail Kosiborod MD, and Alison L. Bailey MD, FACC, discuss ESC Hot Line: STEP HFpEF: once-weekly
Sep 19, 2023
Results presented at the European Society of Cardiology Congress 2023 further support the long-term use of bempedoic acid in patients at high-risk of cardiovascular events and demonstrate particular benefit in those with diabetes. In this interview, Stephen J. Nicholls MBBS, PhD, FACC and Erin D. Michos, MD, MHS, FACC,...
Sep 12, 2023
What is known about the use of wearables and their impact on health outcomes and healthcare use among patients with atrial fibrillation.
In this interview, Dipak Kotecha MBChB, PhD and Sidney C. Smith Jr. MD, MACC, discuss “ESC Late-Breaker: RATE-AF trial wearables study.”
Subscribe on Apple Podcasts |
Sep 8, 2023
In selected countries from each of the six WHO regions, the INTERASPIRE survey is being conducted to provide a unique picture of CHD patients, their cardiometabolic, renal and biomarker status, lifestyle and therapeutic management, and the quality of preventive care in their region.
In this interview, John W. McEvoy...